Q1 2025 Inspire Medical Systems Inc Earnings Call Transcript
Key Points
- Inspire Medical Systems Inc (INSP) achieved a significant milestone by surpassing 100,000 patients who have received Inspire therapy.
- The company reported a strong financial performance with a 23% increase in revenue for the first quarter of 2025, reaching $201.3 million.
- Inspire Medical Systems Inc (INSP) announced the full launch of the Inspire V system in the US, which is expected to enhance therapy capabilities and broaden indications.
- The company has successfully incorporated CPT Code 64568 into policies covering approximately 80% of their over 300 million covered lives, including commercial payers, Medicare, and the VA system.
- Inspire Medical Systems Inc (INSP) is increasing its full-year diluted net income guidance to a range of $2.20 to $2.30 per share, reflecting confidence in future profitability.
- The second quarter of 2025 is expected to be a transition period due to the launch of the Inspire V system, which may impact revenue growth.
- Revenue outside the US decreased by 6% year-over-year, indicating challenges in international markets.
- The company anticipates some inventory destocking of Inspire IV and patient warehousing for Inspire V, which could affect short-term financial performance.
- Operating expenses increased by 11% compared to the first quarter of 2024, primarily due to the expansion of the sales organization and increased general corporate costs.
- There is a potential risk of delays in the transition to the Inspire V system, which could impact the timing of revenue recognition and overall financial performance.
Good afternoon. My name is Dilem, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical Systems First Quarter 2025 Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded.
I will now hand the call over to your first speaker, Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference.
Thank you, Dilem, and thank you all for participating in today's call. Joining me are Tim Herbert, Chairman and Chief Executive Officer; and Richard Buchholz, Chief Financial Officer. Earlier today, we released financial results for the three months ended March 31, 2025. The a copy of the press release is available on our website. On this call, management will make forward-looking statements within the meaning of the federal securities laws.
All forward-looking statements, including without limitation, those relating to our operations, financial
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
